Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Class A Common Shares
-
Shares outstanding
-
98,656,192
-
Total 13F shares
-
5,288,416
-
Share change
-
-91,690
-
Total reported value
-
$6,964,240
-
Put/Call ratio
-
0%
-
Price per share
-
$1.32
-
Number of holders
-
24
-
Value change
-
-$155,145
-
Number of buys
-
11
-
Number of sells
-
13
Institutional Holders of Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) as of Q2 2022
As of 30 Jun 2022,
Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,288,416 shares.
The largest 10 holders included
MMCAP International Inc. SPC, Mirae Asset Global Investments Co., Ltd., Vident Investment Advisory, LLC, ADVISOR GROUP HOLDINGS, INC., TWO SIGMA ADVISERS, LP, GEODE CAPITAL MANAGEMENT, LLC, Marble Harbor Investment Counsel, LLC, Robertson Stephens Wealth Management, LLC, CITADEL ADVISORS LLC, and ROYAL BANK OF CANADA.
This page lists
24
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.